Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease.
Lauten
Wright B
WB
Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia 30303, USA.
Khan
Qamar A
QA
Rajagopalan
Sanjay
S
Lerakis
Stamatios
S
Rahman
Syed T
ST
Parthasarathy
Sampath
S
Khan
Bobby V
BV
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D000069059:Atorvastatin; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D008078:Cholesterol, LDL / Q000097:blood; D003327:Coronary Disease / Q000188:drug therapy* / Q000276:immunology; D004359:Drug Therapy, Combination; D005260:Female; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D000077405:Irbesartan; D007546:Isoquinolines / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009000:Monocytes / Q000378:metabolism*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011758:Pyrroles / Q000627:therapeutic use; D000077583:Quinapril; D044005:Tetrahydroisoquinolines; D013777:Tetrazoles / Q000627:therapeutic use*
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000924:Anticholesteremic Agents; D001713:Biphenyl Compounds; D008078:Cholesterol, LDL; D006538:Heptanoic Acids; D015850:Interleukin-6; D007546:Isoquinolines; D010975:Platelet Aggregation Inhibitors; D011758:Pyrroles; D044005:Tetrahydroisoquinolines; D013777:Tetrazoles; D000069059:Atorvastatin; D000077405:Irbesartan; D001241:Aspirin; D000077583:Quinapril